Presatovir (GS-5806) is an antiviral drug which was developed as a treatment for respiratory syncytial virus.

[1][2] It acts as a fusion inhibitor, and has shown promising results in Phase II clinical trials.

[3][4] This antiinfective drug article is a stub.

You can help Wikipedia by expanding it.